- Home
- OSUR vs REAL Comparison
OSUR vs REAL Comparison
Compare OSUR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- REAL
- Stock Information
- Founded
- OSUR 2000
- REAL 2011
- Country
- OSUR United States
- REAL United States
- Employees
- OSUR N/A
- REAL N/A
- Industry
- OSUR Medical/Dental Instruments
- REAL Other Specialty Stores
- Sector
- OSUR Health Care
- REAL Consumer Discretionary
- Exchange
- OSUR Nasdaq
- REAL Nasdaq
- Market Cap
- OSUR 289.4M
- REAL 982.8M
- IPO Year
- OSUR 1986
- REAL 2019
- Fundamental
- Price
- OSUR $3.62
- REAL $10.02
- Analyst Decision
- OSUR Hold
- REAL Buy
- Analyst Count
- OSUR 2
- REAL 6
- Target Price
- OSUR $5.50
- REAL $7.04
- AVG Volume (30 Days)
- OSUR 1.0M
- REAL 3.8M
- Earning Date
- OSUR 11-06-2024
- REAL 11-04-2024
- Dividend Yield
- OSUR N/A
- REAL N/A
- EPS Growth
- OSUR N/A
- REAL N/A
- EPS
- OSUR 0.15
- REAL N/A
- Revenue
- OSUR $224,263,000.00
- REAL $579,862,000.00
- Revenue This Year
- OSUR N/A
- REAL $11.26
- Revenue Next Year
- OSUR N/A
- REAL $8.81
- P/E Ratio
- OSUR $24.43
- REAL N/A
- Revenue Growth
- OSUR N/A
- REAL 2.52
- 52 Week Low
- OSUR $3.58
- REAL $1.52
- 52 Week High
- OSUR $8.45
- REAL $9.78
- Technical
- Relative Strength Index (RSI)
- OSUR 37.25
- REAL 73.33
- Support Level
- OSUR $3.76
- REAL $9.00
- Resistance Level
- OSUR $3.70
- REAL $9.73
- Average True Range (ATR)
- OSUR 0.17
- REAL 0.73
- MACD
- OSUR -0.03
- REAL -0.03
- Stochastic Oscillator
- OSUR 0.83
- REAL 88.06
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.